Enantioselective synthesis of stephacidin B
Enantioselective synthesis of stephacidin B
复制标题
DOI:
10.1021/ja0510616
复制
发表时间:
2005-04-20
影响因子:
15
通讯作者:
Myers, AG
中科院分区:
文献类型:
--
作者:
Herzon, SB;Myers, AG
We describe an enantioselective synthetic route to the antiproliferative alkaloid stephacidin B (1) proceeding in 18 steps and 4.0% yield from 4,4-(ethylenedioxy)-2,2-dimethylcyclohexanone (3). Key features of the synthetic sequence include the use of the Corey−Bakshi−Shibata (CBS) reduction to introduce asymmetry early in the synthetic route, use of the novel electrophileN-(tert-butoxycarbonyl)-5-(isopropylsulfonyloxymethyl)-2,3-dihydropyrrole in a stereoselective enolate alkylation, a diastereoselective Strecker-type addition of hydrogen cyanide to anN-Boc enamine substrate in the solvent hexafluoroisopropanol, platinum-catalyzed nitrile hydrolysis under neutral conditions, cyclization of an acylamino radical intermediate to form the diketopiperazine core of stephacidin B, and implementation of a convergent procedure for introduction of the key 3-alkylidene-3H-indole 1-oxide functional group in the final stage of the route to prepare the structure2, previously proposed to be the fungal metabolite avrainvillamide (17 steps, 4.2% yield). We observed that synthetic (−)-2dimerized in the presence of triethylamine to form (+)-stephacidin B (>95%). We also obtained evidence that2can form1under mild conditions, and that2reacts with nucleophiles, such as methanol, by conjugate addition.